{"transactions":[{"id":692943,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25402,"kind":"person","name":"Mulligan Seamus","position":1,"cik":"0001536639","reported_name":"Mulligan Seamus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-08-07T21:42:20.000Z","date":"2026-08-05","kind":"grant","planned":false,"acquired":true,"shares":1605,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 23, 2027."}],"balance_after":1184633,"source":{"system":"sec-edgar","filing":"0001536639-26-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000153663926000004/edgardoc.xml","form_type":"4"}},{"id":756850,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25402,"kind":"person","name":"Mulligan Seamus","position":1,"cik":"0001536639","reported_name":"Mulligan Seamus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-06-01T20:01:41.000Z","date":"2026-05-28","kind":"exercise","planned":false,"acquired":false,"shares":3415,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This non-qualified stock option was granted on August 11, 2016 and vested over the period from September 1, 2016 through August 1, 2017. The options were fully vested as of August 1, 2017."}],"balance_after":0,"derivative":{"exercise_price":138.08,"expiration_date":"2026-08-10","underlying":"Ordinary Shares","underlying_shares":3415},"source":{"system":"sec-edgar","filing":"0001536639-26-000002","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000153663926000002/edgardoc.xml","form_type":"4"}},{"id":756849,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25402,"kind":"person","name":"Mulligan Seamus","position":1,"cik":"0001536639","reported_name":"Mulligan Seamus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-01T20:01:41.000Z","date":"2026-05-28","kind":"exercise","planned":false,"acquired":true,"shares":3415,"price":138.08,"value":471543.2,"ownership":{"direct":true},"balance_after":1183028,"source":{"system":"sec-edgar","filing":"0001536639-26-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000153663926000002/edgardoc.xml","form_type":"4"}},{"id":1069955,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25402,"kind":"person","name":"Mulligan Seamus","position":1,"cik":"0001536639","reported_name":"Mulligan Seamus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:32:47.000Z","date":"2025-08-07","kind":"grant","planned":false,"acquired":true,"shares":3507,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 24, 2026."}],"balance_after":1179613,"source":{"system":"sec-edgar","filing":"0001765581-25-000076","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558125000076/edgardoc.xml","form_type":"4"}},{"id":1150645,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25402,"kind":"person","name":"Mulligan Seamus","position":1,"cik":"0001536639","reported_name":"Mulligan Seamus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-05-13T22:51:34.000Z","date":"2025-05-12","kind":"purchase","planned":false,"acquired":true,"shares":1621,"price":102.9991,"value":166961.5411,"ownership":{"direct":false,"nature":"By Nerano Pharma Lim"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects the purchase of ordinary shares executed in multiple transactions at prices ranging from $102.97 to $103.00. The price reported reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the purchases were effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares beneficially owned by Nerano Pharma Limited, an entity owned and controlled by the reporting person and his immediate family."}],"balance_after":101621,"source":{"system":"sec-edgar","filing":"0001765581-25-000042","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558125000042/edgardoc.xml","form_type":"4"}},{"id":1150644,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25402,"kind":"person","name":"Mulligan Seamus","position":1,"cik":"0001536639","reported_name":"Mulligan Seamus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-05-13T22:51:34.000Z","date":"2025-05-09","kind":"purchase","planned":false,"acquired":true,"shares":100,"price":99.71,"value":9971.0,"ownership":{"direct":false,"nature":"By Nerano Pharma Lim"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares beneficially owned by Nerano Pharma Limited, an entity owned and controlled by the reporting person and his immediate family."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001765581-25-000042","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558125000042/edgardoc.xml","form_type":"4"}},{"id":1150643,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25402,"kind":"person","name":"Mulligan Seamus","position":1,"cik":"0001536639","reported_name":"Mulligan Seamus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-05-13T22:51:34.000Z","date":"2025-05-09","kind":"purchase","planned":false,"acquired":true,"shares":19216,"price":98.9112,"value":1900677.6192,"ownership":{"direct":false,"nature":"By Nerano Pharma Lim"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the purchase of ordinary shares executed in multiple transactions at prices ranging from $98.56 to $99.47. The price reported reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the purchases were effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares beneficially owned by Nerano Pharma Limited, an entity owned and controlled by the reporting person and his immediate family."}],"balance_after":99900,"source":{"system":"sec-edgar","filing":"0001765581-25-000042","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558125000042/edgardoc.xml","form_type":"4"}},{"id":1150642,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25402,"kind":"person","name":"Mulligan Seamus","position":1,"cik":"0001536639","reported_name":"Mulligan Seamus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-05-13T22:51:34.000Z","date":"2025-05-09","kind":"purchase","planned":false,"acquired":true,"shares":80684,"price":98.1046,"value":7915471.5464,"ownership":{"direct":false,"nature":"By Nerano Pharma Lim"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the purchase of ordinary shares executed in multiple transactions at prices ranging from $97.56 to $98.5542. The price reported reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the purchases were effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares beneficially owned by Nerano Pharma Limited, an entity owned and controlled by the reporting person and his immediate family."}],"balance_after":80684,"source":{"system":"sec-edgar","filing":"0001765581-25-000042","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558125000042/edgardoc.xml","form_type":"4"}},{"id":1439498,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25402,"kind":"person","name":"Mulligan Seamus","position":1,"cik":"0001536639","reported_name":"Mulligan Seamus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2024-08-06T20:52:22.000Z","date":"2024-08-02","kind":"grant","planned":false,"acquired":true,"shares":3731,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 25, 2025."}],"balance_after":1176106,"source":{"system":"sec-edgar","filing":"0001765581-24-000070","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558124000070/edgardoc.xml","form_type":"4"}},{"id":1807124,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25402,"kind":"person","name":"Mulligan Seamus","position":1,"cik":"0001536639","reported_name":"Mulligan Seamus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-08-15T21:56:43.000Z","date":"2023-08-11","kind":"grant","planned":false,"acquired":true,"shares":3075,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on August 3, 2024."}],"balance_after":1172375,"source":{"system":"sec-edgar","filing":"0001765581-23-000086","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558123000086/edgardoc.xml","form_type":"4"}},{"id":1858538,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25402,"kind":"person","name":"Mulligan Seamus","position":1,"cik":"0001536639","reported_name":"Mulligan Seamus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-06-12T20:47:04.000Z","date":"2023-06-08","kind":"exercise","planned":false,"acquired":false,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This non-qualified stock option was granted on August 8, 2013 and vested over a period of one year from September 1, 2013. The options were fully vested as of August 1, 2014."}],"balance_after":0,"derivative":{"exercise_price":81.76,"expiration_date":"2023-08-07","underlying":"Ordinary Shares","underlying_shares":4500},"source":{"system":"sec-edgar","filing":"0001765581-23-000052","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558123000052/edgardoc.xml","form_type":"4"}},{"id":1858537,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25402,"kind":"person","name":"Mulligan Seamus","position":1,"cik":"0001536639","reported_name":"Mulligan Seamus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-06-12T20:47:04.000Z","date":"2023-06-08","kind":"exercise","planned":false,"acquired":true,"shares":4500,"price":81.76,"value":367920.0,"ownership":{"direct":true},"balance_after":1169300,"source":{"system":"sec-edgar","filing":"0001765581-23-000052","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558123000052/edgardoc.xml","form_type":"4"}},{"id":1965444,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25402,"kind":"person","name":"Mulligan Seamus","position":1,"cik":"0001536639","reported_name":"Mulligan Seamus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-03-08T01:30:59.000Z","date":"2023-03-04","kind":"exercise","acquired":false,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Option Plan and vested in 12 monthly installments over one year from the grant date, March 5, 2013."}],"balance_after":0,"derivative":{"exercise_price":59.13,"expiration_date":"2023-03-04","underlying":"Ordinary Shares","underlying_shares":4500},"source":{"system":"sec-edgar","filing":"0001765581-23-000010","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558123000010/edgardoc.xml","form_type":"4"}},{"id":1965443,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25402,"kind":"person","name":"Mulligan Seamus","position":1,"cik":"0001536639","reported_name":"Mulligan Seamus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-03-08T01:30:59.000Z","date":"2023-03-04","kind":"exercise","acquired":true,"shares":4500,"price":59.13,"value":266085.0,"ownership":{"direct":true},"balance_after":1164800,"source":{"system":"sec-edgar","filing":"0001765581-23-000010","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558123000010/edgardoc.xml","form_type":"4"}},{"id":2190630,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25402,"kind":"person","name":"Mulligan Seamus","position":1,"cik":"0001536639","reported_name":"Mulligan Seamus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-08-09T22:31:03.000Z","date":"2022-08-05","kind":"grant","acquired":true,"shares":2561,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 28, 2023."}],"balance_after":1160300,"source":{"system":"sec-edgar","filing":"0001765581-22-000090","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000090/edgardoc.xml","form_type":"4"}},{"id":2619821,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25402,"kind":"person","name":"Mulligan Seamus","position":1,"cik":"0001536639","reported_name":"Mulligan Seamus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-08-02T22:18:59.000Z","date":"2021-07-29","kind":"grant","acquired":true,"shares":2246,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 29, 2022."}],"balance_after":1157739,"source":{"system":"sec-edgar","filing":"0001765581-21-000075","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558121000075/edgardoc.xml","form_type":"4"}},{"id":3063263,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25402,"kind":"person","name":"Mulligan Seamus","position":1,"cik":"0001536639","reported_name":"Mulligan Seamus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-08-10T20:47:02.000Z","date":"2020-08-06","kind":"grant","acquired":true,"shares":6765,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan.  Subject to the Reporting Person's continuous service and certain additional conditions, these options will vest in full on July 30, 2021."}],"balance_after":6765,"derivative":{"exercise_price":127.07,"expiration_date":"2030-08-05","underlying":"Ordinary Shares","underlying_shares":6765},"source":{"system":"sec-edgar","filing":"0001765581-20-000075","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558120000075/edgardoc.xml","form_type":"4"}},{"id":3063262,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25402,"kind":"person","name":"Mulligan Seamus","position":1,"cik":"0001536639","reported_name":"Mulligan Seamus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2020-08-10T20:47:02.000Z","date":"2020-08-06","kind":"grant","acquired":true,"shares":2705,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 30, 2021."}],"balance_after":1155493,"source":{"system":"sec-edgar","filing":"0001765581-20-000075","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558120000075/edgardoc.xml","form_type":"4"}},{"id":3133409,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25402,"kind":"person","name":"Mulligan Seamus","position":1,"cik":"0001536639","reported_name":"Mulligan Seamus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2020-05-27T22:36:05.000Z","date":"2020-05-27","kind":"purchase","acquired":true,"shares":11482,"price":112.3189,"value":1289645.6098,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Reflects the purchase of ordinary shares executed in multiple transactions at prices ranging from $112.0500 to $112.6600. The price reported reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the purchases were effected."}],"balance_after":1152788,"source":{"system":"sec-edgar","filing":"0001765581-20-000055","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558120000055/edgardoc.xml","form_type":"4"}},{"id":3133408,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25402,"kind":"person","name":"Mulligan Seamus","position":1,"cik":"0001536639","reported_name":"Mulligan Seamus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2020-05-27T22:36:05.000Z","date":"2020-05-27","kind":"purchase","acquired":true,"shares":9884,"price":111.5623,"value":1102681.7732,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects the purchase of ordinary shares executed in multiple transactions at prices ranging from $111.0350 to $112.0200. The price reported reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the purchases were effected."}],"balance_after":1141306,"source":{"system":"sec-edgar","filing":"0001765581-20-000055","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558120000055/edgardoc.xml","form_type":"4"}},{"id":3133407,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25402,"kind":"person","name":"Mulligan Seamus","position":1,"cik":"0001536639","reported_name":"Mulligan Seamus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2020-05-27T22:36:05.000Z","date":"2020-05-27","kind":"purchase","acquired":true,"shares":8391,"price":110.5174,"value":927351.5034,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the purchase of ordinary shares executed in multiple transactions at prices ranging from 110.0300 to $111.0100. The price reported reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the purchases were effected."}],"balance_after":1131422,"source":{"system":"sec-edgar","filing":"0001765581-20-000055","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558120000055/edgardoc.xml","form_type":"4"}},{"id":3133406,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25402,"kind":"person","name":"Mulligan Seamus","position":1,"cik":"0001536639","reported_name":"Mulligan Seamus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2020-05-27T22:36:05.000Z","date":"2020-05-27","kind":"purchase","acquired":true,"shares":5243,"price":109.5516,"value":574379.0388,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the purchase of ordinary shares executed in multiple transactions at prices ranging from $109.0300 to $110.0200. The price reported reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the purchases were effected."}],"balance_after":1123031,"source":{"system":"sec-edgar","filing":"0001765581-20-000055","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558120000055/edgardoc.xml","form_type":"4"}},{"id":3133405,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25402,"kind":"person","name":"Mulligan Seamus","position":1,"cik":"0001536639","reported_name":"Mulligan Seamus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2020-05-27T22:36:05.000Z","date":"2020-05-26","kind":"purchase","acquired":true,"shares":15000,"price":110.6498,"value":1659747.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the purchase of ordinary shares executed in multiple transactions at prices ranging from $110.1800 to $110.9800. The price reported reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the purchases were effected."}],"balance_after":1117788,"source":{"system":"sec-edgar","filing":"0001765581-20-000055","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558120000055/edgardoc.xml","form_type":"4"}},{"id":3440869,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25402,"kind":"person","name":"Mulligan Seamus","position":1,"cik":"0001536639","reported_name":"Mulligan Seamus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2019-08-12T21:27:52.000Z","date":"2019-08-08","kind":"grant","acquired":true,"shares":4805,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These options are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan.  Subject to the Reporting Person's continuous service and certain additional conditions, these options will vest in 12 equal monthly installments beginning on September 1, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan.  Subject to the Reporting Person's continuous service and certain additional conditions, these options will vest in 12 equal monthly installments beginning on September 1, 2019."}],"balance_after":4805,"derivative":{"exercise_price":137.12,"expiration_date":"2029-08-07","underlying":"Ordinary Shares","underlying_shares":4805},"source":{"system":"sec-edgar","filing":"0001765581-19-000068","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558119000068/edgardoc.xml","form_type":"4"}},{"id":3440868,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25402,"kind":"person","name":"Mulligan Seamus","position":1,"cik":"0001536639","reported_name":"Mulligan Seamus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-08-12T21:27:52.000Z","date":"2019-08-08","kind":"grant","acquired":true,"shares":1920,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on August 1, 2020."}],"balance_after":1102788,"source":{"system":"sec-edgar","filing":"0001765581-19-000068","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558119000068/edgardoc.xml","form_type":"4"}},{"id":3582703,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25402,"kind":"person","name":"Mulligan Seamus","position":1,"cik":"0001536639","reported_name":"Mulligan Seamus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-21T20:18:12.000Z","date":"2019-03-19","kind":"grant","acquired":true,"shares":7569,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Mr. Mulligan and his family, collectively hold an aggregate 100% equity interest in Nerano Pharma Ltd, which in turn is the direct owner of 545,590 shares of the Issuer's common stock."},{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."}],"balance_after":56141,"source":{"system":"sec-edgar","filing":"0001567619-19-007364","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761919007364/doc1.xml","form_type":"4"}},{"id":3758592,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25402,"kind":"person","name":"Mulligan Seamus","position":1,"cik":"0001536639","reported_name":"Mulligan Seamus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2018-11-19T22:32:56.000Z","date":"2018-11-15","kind":"purchase","acquired":true,"shares":22137,"price":145.0464,"value":3210892.1568,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects the purchase of ordinary shares executed in multiple transactions at prices ranging from $144.69 to $145.56. The price reported reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the purchases were effected."}],"balance_after":1100868,"source":{"system":"sec-edgar","filing":"0001232524-18-000196","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252418000196/edgardoc.xml","form_type":"4"}},{"id":3758591,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25402,"kind":"person","name":"Mulligan Seamus","position":1,"cik":"0001536639","reported_name":"Mulligan Seamus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2018-11-19T22:32:56.000Z","date":"2018-11-15","kind":"purchase","acquired":true,"shares":26363,"price":144.2431,"value":3802680.8453,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the purchase of ordinary shares executed in multiple transactions at prices ranging from $143.69 to $144.67. The price reported reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the purchases were effected."}],"balance_after":1078731,"source":{"system":"sec-edgar","filing":"0001232524-18-000196","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252418000196/edgardoc.xml","form_type":"4"}},{"id":3758590,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25402,"kind":"person","name":"Mulligan Seamus","position":1,"cik":"0001536639","reported_name":"Mulligan Seamus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2018-11-19T22:32:56.000Z","date":"2018-11-15","kind":"purchase","acquired":true,"shares":1200,"price":143.2242,"value":171869.04,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the purchase of ordinary shares executed in multiple transactions at prices ranging from $142.67 to $143.60. The price reported reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the purchases were effected."}],"balance_after":1052368,"source":{"system":"sec-edgar","filing":"0001232524-18-000196","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252418000196/edgardoc.xml","form_type":"4"}},{"id":3758589,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25402,"kind":"person","name":"Mulligan Seamus","position":1,"cik":"0001536639","reported_name":"Mulligan Seamus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2018-11-19T22:32:56.000Z","date":"2018-11-15","kind":"purchase","acquired":true,"shares":300,"price":141.8633,"value":42558.99,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the purchase of ordinary shares executed in multiple transactions at prices ranging from $141.52 to $142.04. The price reported reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the purchases were effected."}],"balance_after":1051168,"source":{"system":"sec-edgar","filing":"0001232524-18-000196","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252418000196/edgardoc.xml","form_type":"4"}},{"id":3846036,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25402,"kind":"person","name":"Mulligan Seamus","position":1,"cik":"0001536639","reported_name":"Mulligan Seamus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-08-13T23:07:37.000Z","date":"2018-08-09","kind":"grant","acquired":true,"shares":3735,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These options are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan.  Subject to the Reporting Person's continuous service and certain additional conditions, these options will vest in 12 equal monthly installments beginning on September 1, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan.  Subject to the Reporting Person's continuous service and certain additional conditions, these options will vest in 12 equal monthly installments beginning on September 1, 2018."}],"balance_after":3735,"derivative":{"exercise_price":177.73,"expiration_date":"2028-08-08","underlying":"Ordinary Shares","underlying_shares":3735},"source":{"system":"sec-edgar","filing":"0001232524-18-000156","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252418000156/edgardoc.xml","form_type":"4"}},{"id":3846035,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25402,"kind":"person","name":"Mulligan Seamus","position":1,"cik":"0001536639","reported_name":"Mulligan Seamus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2018-08-13T23:07:37.000Z","date":"2018-08-09","kind":"grant","acquired":true,"shares":1495,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on August 2, 2019."}],"balance_after":1050868,"source":{"system":"sec-edgar","filing":"0001232524-18-000156","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252418000156/edgardoc.xml","form_type":"4"}},{"id":4235119,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25402,"kind":"person","name":"Mulligan Seamus","position":1,"cik":"0001536639","reported_name":"Mulligan Seamus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-08-14T21:23:16.000Z","date":"2017-08-10","kind":"grant","acquired":true,"shares":3415,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These options are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan.  Subject to the Reporting Person's continuous service and certain additional conditions, these options will vest in 12 equal monthly installments beginning on September 1, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan.  Subject to the Reporting Person's continuous service and certain additional conditions, these options will vest in 12 equal monthly installments beginning on September 1, 2017."}],"balance_after":3415,"derivative":{"exercise_price":143.66,"expiration_date":"2027-08-09","underlying":"Ordinary Shares","underlying_shares":3415},"source":{"system":"sec-edgar","filing":"0001232524-17-000144","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252417000144/edgardoc.xml","form_type":"4"}},{"id":4235118,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25402,"kind":"person","name":"Mulligan Seamus","position":1,"cik":"0001536639","reported_name":"Mulligan Seamus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2017-08-14T21:23:16.000Z","date":"2017-08-10","kind":"grant","acquired":true,"shares":1365,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on August 3, 2018."},{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on August 3, 2018."}],"balance_after":1049373,"source":{"system":"sec-edgar","filing":"0001232524-17-000144","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252417000144/edgardoc.xml","form_type":"4"}}]}